Rongxi Wang
Overview
Explore the profile of Rongxi Wang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
48
Citations
140
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wang R, Wang J, Xiang J, Sui H, Li L, Jia C, et al.
J Nucl Med
. 2025 Mar;
PMID: 40049742
Solitary fibrous tumor (SFT) is a rare sarcoma of mesenchymal origin. Although generally benign, SFTs carry the risk of recurrence and metastasis, with limited effective treatment options. The aims of...
2.
Wang R, Gao X, Peng X, Wang J, Xiang J, Li L, et al.
Clin Nucl Med
. 2025 Feb;
PMID: 39988794
Purpose: This study was designed to evaluate 68Ga-pentixafor, which targets C-X-C chemokine receptor 4 (CXCR4), in the noninvasive diagnosis of thymomas. Patients And Methods: With institutional review board approval and...
3.
Gao X, Peng X, Wang R, Qian Z, Zhou X, Zhu Z, et al.
J Cell Mol Med
. 2025 Jan;
29(3):e70248.
PMID: 39887860
Mucosa-associated lymphoid tissue (MALT) lymphoma is an extranodal low-grade non-Hodgkin lymphoma that extremely rarely localises to the mediastinum. A 34-year-old female with chronic arthralgia, sicca and rash was found to...
4.
Wang R, Chen J, Wang J, Zhu Z, Zhang J
Clin Nucl Med
. 2025 Jan;
PMID: 39848236
Primary pulmonary mucosa-associated lymphoid tissue lymphoma is extremely rare. We present the 18F-FDG and 68Ga-FAPI PET/CT findings in a 56-year-old woman with pathologically confirmed primary pulmonary mucosa-associated lymphoid tissue lymphoma....
5.
Li Y, Wang R, Chen J, Zhu Z, Wang Y, Ma W
EJNMMI Res
. 2025 Jan;
15(1):6.
PMID: 39821814
Background: Gliomas are the most common malignant primary tumors of the central nervous system. There is an urgent need for new convenient, targeted and specific imaging agents for gliomas. This...
6.
Wang R, Li Y, Li Z, Wang J, Li L, Xiang J, et al.
Clin Nucl Med
. 2025 Jan;
50(4):316-323.
PMID: 39806560
Purpose: The aim of this study was to investigate the value of 68 Ga-NOTA-RM26 ( 68 Ga-RM26), a gastrin-releasing peptide receptor-targeting antagonist labeled with the radionuclide 68 Ga, in the...
7.
Xiong H, Wang R, Zhang H, Zhang Q, Qin Y, Du C, et al.
ACS Nano
. 2025 Jan;
19(3):3953-3965.
PMID: 39806279
The emerging combination of chemotherapy and radionuclide therapy has been actively investigated to overcome the limitations of monotherapy and augment therapeutic efficacy. However, it remains a challenge to design a...
8.
Li L, Wang G, Wang J, Ma H, Chen J, Wang R, et al.
Clin Nucl Med
. 2024 Nov;
50(1):38-43.
PMID: 39499011
Purpose: Modifying glucagon-like peptide-1 receptor (GLP-1R)-targeted PET agent to achieve faster renal clearance and preserved high affinity to GLP-1R is clinically relevant. The aim of this study is to assess...
9.
Xu L, Chang R, Chen Y, Xia D, Xu C, Yu X, et al.
Transgend Health
. 2024 Oct;
9(5):421-426.
PMID: 39449793
Purpose: Drug use is quite common in transgender women, but the mechanisms of the drug use remain unclear. The purpose of this study was to investigate the mediating role of...
10.
Wang R, Kang W, Liu Z, Zheng Y, Sui H, Li L, et al.
J Nucl Med
. 2024 Oct;
66(2):201-206.
PMID: 39448271
Gastrointestinal stromal tumors (GISTs) are the most common stromal tumors in the gastrointestinal tract. This study was designed to evaluate a gastrin-releasing peptide receptor antagonist PET tracer, [Ga]Ga-NOTA-RM26, and compare...